Patent details
EP3842034 Title: ANTICANCER COMPOSITIONS
Basic Information
- Publication number:
- EP3842034
- PCT Application Number:
- Type:
- European Patent Granted for LU
- Legal Status:
- In force
- Application number:
- EP202095592
- PCT Publication Number:
- First applicant's nationality:
- Translation Language:
- EPO Publication Language:
- English
- English Title of Invention:
- ANTICANCER COMPOSITIONS
- French Title of Invention:
- COMPOSITIONS ANTICANCÉREUSES
- German Title of Invention:
- ANTIKREBSZUSAMMENSETZUNGEN
- SPC Number:
Dates
- Filing date:
- 03/12/2015
- Grant date:
- 12/02/2025
- EP Publication Date:
- 30/06/2021
- PCT Publication Date:
- Claims Translation Received Date:
- Translations Received Date (B1 EP Publication):
- Translations Received Date (B2 EP Publication):
- Translations Received Date (B3 EP Publication):
- Publication date:
- 12/02/2025
- EP B1 Publication Date:
- 12/02/2025
- EP B2 Publication Date:
- EP B3 Publication Date:
- Lapsed date:
- Expiration date:
- 03/12/2035
- Renunciation date:
- Revocation date:
- Annulment date:
Owner
- From:
- 05/02/2025
- Name:
- Aragon Pharmaceuticals, Inc.
- Address:
- 10990 Wilshire Blvd. Suite 440, Los Angeles, CA 90024, United States (US)
Inventor
- Name:
- VERRECK, Geert
- Address:
- Belgium (BE)
Priority
- Priority Number:
- 14196591
- Priority Date:
- 05/12/2014
- Priority Country:
- European Patent Office (EPO) (EP)
Classification
- IPC classification:
- A61K 9/00; A61K 9/14; A61K 9/20; A61P 13/08; A61K 31/4439; A61P 35/04; A61P 35/00;
Publication
European Patent Bulletin
- Issue number:
- 202507
- Publication date:
- 12/02/2025
- Description:
- Grant (B1)
Annual Fees
- Annual Fee Due Date:
- 31/12/2025
- Annual Fee Number:
- 11
- Annual Fee Amount:
- 148 Euro
- Expected Payer:
- Last Annual Fee Payment Date:
- Last Annual Fee Paid Number:
- Payer:
| Filing date | Document type | Number of pages |
|---|